Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
02/14/2006 | CA2245197C Unsaturated derivatives in position -4 of 6-tert-butyl-1, 1-dimethylindan and their use in human or veterinary medicine and in cosmetics |
02/14/2006 | CA2241094C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
02/14/2006 | CA2241093C Tri-substituted phenyl derivatives useful as pde iv inhibitors |
02/14/2006 | CA2105666C New centrally acting substituted phenylazacycloalkanes |
02/09/2006 | WO2006013049A2 Benzyloxy derivatives as maob inhibitors |
02/09/2006 | WO2005123670A3 Crystalline form of a substituted pyrrolidine compound |
02/09/2006 | US20060030708 Methods for the preparation of pyrrolotriazine compounds |
02/09/2006 | US20060030599 Sulphonamide derivatives |
02/09/2006 | US20060030553 Cell adhesion inhibitors |
02/09/2006 | DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments |
02/09/2006 | DE102004035164A1 Neue o-Aminophenol-Derivate und diese Verbindungen enthaltende Färbemittel New o-aminophenol derivatives and compounds containing colorants |
02/09/2006 | CA2575018A1 Benzyloxy derivatives as maob inhibitors |
02/08/2006 | EP1623975A1 Process for producing pyrrolidine derivative |
02/08/2006 | EP1622870A2 Glutaminyl based dp iv-inhibitors |
02/08/2006 | EP1622868A1 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives |
02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
02/08/2006 | CN1732165A 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
02/08/2006 | CN1732156A Biphenyl derivatives and their use as fungicides |
02/08/2006 | CN1240699C Remedies or preventives for diseases in association with chemokines |
02/08/2006 | CN1240691C Substituted penta azacylo compounds and their use for preventing and treating nervous retrogression disease |
02/08/2006 | CN1240681C Nitrile derivatives as cathepsin K inhibitors |
02/08/2006 | CN1240679C 2- and 2,5-substituted phenylketoenols |
02/08/2006 | CN1240678C Method for the production of delta <1> pyrrolines |
02/07/2006 | US6995283 Benzophenones as inhibitors of reverse transcriptase |
02/07/2006 | US6995275 Preparing an ink jet ink composition by contacting the resulting lactam with colorant(s); efficient, one step low cost process |
02/07/2006 | US6995185 Δ1-pyrrolines used as pesticides |
02/07/2006 | US6995183 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods |
02/07/2006 | US6995182 1-sulfonyl pyrrolidine derivatives |
02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
02/07/2006 | US6995174 for inhibiting proteases |
02/07/2006 | US6995142 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
02/07/2006 | US6995006 Incubating a producer cell in a cell culture medium; wherein the producer cell is other than a KB cell, whereby greater than about 102 particles are produced from the producer cell |
02/07/2006 | CA2450111C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
02/07/2006 | CA2360308C Glucocorticoid receptor modulators |
02/07/2006 | CA2200433C Phenyloxazolidinone antimicrobials |
02/02/2006 | WO2006012499A2 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
02/02/2006 | WO2006012227A2 Amido compounds and their use as pharmaceuticals |
02/02/2006 | WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
02/02/2006 | WO2006011155A1 One pot process for amorphous atorvastain calcium |
02/02/2006 | WO2006011041A2 Crystalline forms of (r-(r*))-2-(4-fluorophenyl)-beta, gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-1-hept anoic acid calcium salt (2:1) |
02/02/2006 | WO2006011035A1 Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them |
02/02/2006 | WO2005097203A3 Serum protein conjugates of ion channel modulating compounds and uses thereof |
02/02/2006 | US20060025602 Process for making N-vinyl-2-pyrrolidone |
02/02/2006 | US20060025596 Method for deuteration or tritiation of heterocyclic ring |
02/02/2006 | US20060025474 Bisphenyl compounds useful as vitamin D3 receptor agonists |
02/02/2006 | US20060025472 Fungicidal carboxamides |
02/02/2006 | US20060025459 Having Asp2 ( beta -secretase, BACE1 or Memapsin) inhibitory activity, for therapy of diseases characterised by elevated beta -amyloid levels or beta -amyloid deposits |
02/02/2006 | US20060025412 Enzyme inhibitors as bactericides for infections |
02/02/2006 | US20060024704 Detection of markers in nascent proteins |
02/02/2006 | DE102004033021A1 Liquid pressure transmitting medium, useful in hydraulic component or machines, comprises ionic liquid as pressure transmitting medium |
02/02/2006 | CA2754932A1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
02/02/2006 | CA2701710A1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
02/02/2006 | CA2575518A1 Medicinal composition as immunosuppressant |
02/02/2006 | CA2575359A1 Piperazine derivatives useful for the treatment of gastrointestinal disorders |
02/02/2006 | CA2575243A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
02/02/2006 | CA2574418A1 Peptidase inhibitors |
02/02/2006 | CA2574361A1 1, 3 substituted cycloamino derivatives and their use as histamine-3 receptor antagonists |
02/02/2006 | CA2573426A1 Pyrrole derivatives as pharmaceutical agents |
02/02/2006 | CA2570694A1 Amido compounds and their use as pharmaceuticals |
02/01/2006 | EP1621598A1 Divinylfluorenes. |
02/01/2006 | EP1620495A2 Imide-linked maleimide and polymaleimide compounds |
02/01/2006 | EP1620432A1 Nk-2 antagonist basic linear compounds and formulations containing them |
02/01/2006 | EP1620396A1 Process for the preparation of n-substituted 2-cyanopyrrolidines |
02/01/2006 | EP1620394A1 Method for crystallizing guanidinium salts |
02/01/2006 | EP1620235A1 Processing method and processing device |
02/01/2006 | EP1620091A2 Inhibitors of glutaminyl cyclase |
02/01/2006 | EP0817765B1 Stereoselective ring opening reactions |
02/01/2006 | CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
02/01/2006 | CN1727341A Process for preparing 2-pyrrolidinyl-3h,5h-pyrrolo[3,2-d]pyrimidine -4-ketone derivative |
02/01/2006 | CN1727335A Photoinitiator of benzophenone containing N-phenyl maleimide base group, and preparation method |
02/01/2006 | CN1239495C Fungicides for control of take-all disease of plants |
02/01/2006 | CN1239451C Process for preparing chiral desubstituted carbinol with high selectivity |
01/31/2006 | US6992205 Process for the production of sulfonic esters |
01/31/2006 | US6992195 Production of N-aryl-2-lactam and N-cycloalkyl-2-lactam by reductive amination of lactones with arylamines |
01/31/2006 | US6992194 suspending crystal strutured or amorphous lipitor in diluents comprising alcohols and/or water mixtures to cause conversion, then separating the diluents; monodispersity |
01/31/2006 | US6992193 Sulfonylamino phenylacetamide derivatives and methods of their use |
01/31/2006 | US6992103 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |
01/31/2006 | US6992102 Bicyclic modulators of androgen receptor function |
01/31/2006 | US6992097 such as methyl-1-{2-[4-((2R)-2-{2-[(tert-butoxy)carbonylamino]-2-methylpropanoylamino}-3-indol-3-ylpropanoylamino)imidazolyl]-2-phenylacetyl}pyrrolidine-2-carboxylate |
01/31/2006 | US6992095 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
01/31/2006 | US6992076 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals |
01/31/2006 | US6992071 Methods for modulating phototoxicity |
01/31/2006 | US6991778 Use of dendrimers polyl-functionalized with nitroxide groups as contrast enhancing agents in MRI imaging of joints and injectable compositions comprising them |
01/26/2006 | WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
01/26/2006 | WO2006009325A1 Metalloprotease inhibitor |
01/26/2006 | WO2006008644A1 Antidiabetic compounds |
01/26/2006 | WO2006008196A1 Process for preparing nitrooxy esters, nitrooxy thioesters, nitrooxy carbonates and nitrooxy thiocarbonates, intermediates useful in said process and preparation thereof |
01/26/2006 | WO2006008091A2 Oxidative degradation products of atorvastatin calcium |
01/26/2006 | WO2006007896A1 Novel o-aminophenol derivatives and colorants containing said compounds |
01/26/2006 | WO2005077463A3 Ligand for a monoamine receptor or transporter for treating addiction or dependence |
01/26/2006 | WO2005075973A3 Acousto-mechanical detection systems and methods of use |
01/26/2006 | WO2005037205A3 Haloacetamide and azide substituted compounds and methods of use thereof |
01/26/2006 | US20060020137 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
01/26/2006 | US20060020009 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
01/26/2006 | US20060019831 1-(3-trifluoromethyl)phenyl-3-(N-methyl)carboxamido-2-pyrrolidinone; herbicides; high compatibility with crop plants is desirable; no adverse effect on the chlorophyll synthesis in crop plants; crop protection compositions |
01/26/2006 | DE19754322B4 Verfahren zur Herstellung von Salzen cyclischer Amidine A process for the preparation of salts of cyclic amidines |
01/26/2006 | DE112004000331T5 Neue Verbindung und Zusammensetzung, hergestellt unter Verwendung einer solchen Verbindung New compound and composition prepared by using such a compound |
01/26/2006 | CA2833770A1 Oxidative degradation products of atorvastatin calcium |
01/26/2006 | CA2574666A1 Process for preparing nitrooxy esters, nitrooxy thioesters, nitrooxy carbonates and nitrooxy thiocarbonates, intermediates useful in said process and preparation thereof |